Medbelle was conducting research into the cities with the best hospital systems and became aware that one of the biggest disparities across the world, when it comes to access to care, is the price of medicine. This led them to commission a study in order to help shed light on this imbalance, in the hope that addressing this important global issue would provide a pathway to greater medical accessibility.
The result is a comparative index across 50 countries which reveals the differences in cost of some of the most widely recognised and indispensable medications. Our drugs are not included here but it is an insight into relative costs and there is no reason to think that cancer drugs would be any different.
Not surprisingly, the USA pays the most for its drugs with UK at 21st, Canada is 35th and Australia at 40th.
Medbelle, the company that compiled this data is an interesting company based in UK. medbelle.com/about
Prices Index here: medbelle.com/medicine-price...
Jackie
Factors affecting pricing for Ibrutinib and Venetoclax
Does every treatment have a price?
Does anyone know if the Indian pharmaceutical industry has good result in the treatment of CLL 17p?
The price of Imbruvica to go down for U.S. seniors in 2026!
Watching and waiting?
